4 Best Biopharma Stock Trades 2013

Below are some of the best trades in the Biopharma Stock Sector since January 2013. I have gathered my research from a pretty good stock investment forum, 4-Trader.  It's all free.  I would never ask you to pay for anything on my site.  No catches, no gimmicks.

If you want to search for other Sectors or other Countries, you can check them out here:

4-Trader.com Stock Sector Research

4-Trader.com Healthcare Sector:  Biotech and Pharmaceutical 

These are highly potential  breakout stocks that I have researched and just posting their results and how to learn more about these Top Stocks in the Healthcare Sector.  More Specifically Biotech and Pharmaceutical Stocks that I predict will be doing very well in the next year with the stock market doing well and the Obamacare being implemented in 2014.  There were a lot to choose from so I pick the best ones that I thought had potential for further gains.

Make Money Off Obamacare

As bad as Obamacare is for business, I think it will improve the Healthcare Sector in the upcoming year and these are all good stocks that I would recommend.  But you can perform your own due diligence yourself, this are the ones that stuck out to me.

Top 4 Biopharma Trades

These are the all the best trades since January, most are above 50% in stock share growth.  Most have higher potentials for further earnings.  These are my own personal 4 picks that I thought were the best of the bunch.

Santarus Inc. (SNTS)


Antares Pharma: $ATRS A Risky Buy

Antares Pharmaceuticals is a Hot Biopharma Investment Right Now

Antares Pharma
So let's start off with Antares Pharma. Most of my previous stocks that I have written about have done very well in the past few years so I'll continue with that trend with this stock: ATRS.

ATRS FDA Approval PDUFA Date is Oct. 14th

     Antares Pharma

Here's a few web links to help you out on Antares and what they are all about. 

This is what that blogger from Seeking Alpha, Scott Matusow has to say about Antares.  I agree with a commenter that a buyout would be a couple of years down the road.

Antares Pharma (ATRS)

Antares Pharma